Zhongyun Ning
Lanzhou, 730030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Double-negative prostate cancer: Evolutionary mechanisms, microenvironmental remodeling, and clinical translation.
Journal: Critical reviews in oncology/hematology
Published: May 23, 2026
The efficacy and safety of adrenergic alpha-antagonists combined with PDE5 inhibitors in the medical expulsive therapy for unilateral distal ureteral stones: a systematic review and meta-analysis.
Journal: Translational andrology and urology
Published: December 21, 2025
Anastomosing hemangioma of the kidney: a case report.
Journal: Frontiers in oncology
Published: December 14, 2025
Brain metastasis from prostate cancer with neurologic symptoms as the first sign: a case report.
Journal: The aging male : the official journal of the International Society for the Study of the Aging Male
Published: November 26, 2025
A clinical study of RC48-ADC combined with PD-1 inhibitor in bladder preservation therapy for muscle-invasive bladder cancer (MIBC)-based on real-world data analysis.
Journal: International urology and nephrology
Published: February 28, 2025
Robotic-assisted versus laparoscopic adrenalectomy for large adrenal tumors: a systematic review and meta-analysis.
Journal: International urology and nephrology
Published: January 13, 2025
Efficacy and Safety of Muscarinic Antagonists Combined with Adrenergic alpha-Antagonists in the Medical Expulsion Therapy for Distal Ureteral Stone: A Meta-Analysis.
Journal: Urologia internationalis
Published: November 09, 2024
Primary adrenal squamous cell carcinoma: A rare case report.
Journal: Asian journal of surgery
Published: May 13, 2022
Pelvic Plexus Block Versus Periprostatic Nerve Block for Ultrasound-Guided Prostate Biopsy: A Meta-Analysis.
Journal: Frontiers in oncology
Published: January 19, 2021
Trimodal Therapy vs. Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Meta-Analysis.
Journal: Frontiers in oncology
Published: May 22, 2020
2'‑Hydroxyflavanone inhibits epithelial‑mesenchymal transition, and cell migration and invasion via suppression of the Wnt/β‑catenin signaling pathway in prostate cancer.
Journal: Oncology reports
Published: December 16, 2017
[Corrigendum] 2'‑Hydroxyflavanone inhibits epithelial‑mesenchymal transition, and cell migration and invasion via suppression of the Wnt/β‑catenin signaling pathway in prostate cancer.
Journal: Oncology reports
Published: December 16, 2017
Last Updated: 09/26/2026